According to a recent pulse survey from the International Foundation of Employee Benefit Plans: 76 percent of employers already cover GLP-1 drugs for diabetes 27 percent cover the drugs for weight loss 13 percent are considering adding coverage for weight loss 63 percent said the risk of chronic diseases and other costs associated with obesity were a top factor in their GLP-1 coverage decision For employers considering adding the coverage, there are some steps you can take to manage who is able to receive coverage and to help contain costs, according to information from Employers Health: For diabetes, best practices include first confirming there is a diabetes diagnosis and a prior attempt to use a different drug
Microplastics regulate soil microbial activities: evidence from catalase, dehydrogenase, and fluorescein diacetate hydrolase
Cold medication straight from refrigeration causes vasoconstriction, where blood vessels tighten
These new snacking habits
Definition and diagnostic criteria Gamma-glutamyl transpeptidase deficiency is a very rare autosomal recessive disease characterized by increased glutathione concentration in plasma and urine
Penta deca peptide arginate accelerates healing across multiple tissue types, including tendons, ligaments, muscles, skin, and bone
